<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Albany Molecular Research, Inc.
- -------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
Delaware 14-1806984
- ---------------------------------------- ------------------------------------
(State of Incorporation or Organization) (I.R.S. Employer Identification no.)
21 Corporate Circle, Albany, New York 12203
- -------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
<TABLE>
<S> <C>
If this form relates to the If this form relates to the
registration of a class of securities registration of a class of securities
pursuant to Section 12(b) of the pursuant to Section 12(g) of the
Exchange Act and is effective Exchange Act and is effective
pursuant to General Instruction pursuant to General Instruction
A.(c), please check the following A.(d), please check the following
box. [_] box. [X]
</TABLE>
Securities Act registration statement file number to which this form
relates: 333-58795
---------------
(If applicable)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
- ---------------------------------- --------------------------------------
None
- ---------------------------------- --------------------------------------
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, par value $.01 per share
---------------------------------------------------------
(Title of class)
<PAGE>
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of Registrant's Securities to be Registered.
A description of the Common Stock of the Registrant is set forth in
the information provided under "Description of Capital Stock" in the
Prospectus contained in the Registration Statement on Form S-1 (the
"Registration Statement"), filed under the Securities Act of 1933 with the
Securities and Exchange Commission on July 9, 1998, File No. 333-58795, as
amended (including after the date hereof pursuant to Rule 424(b) under the
Securities Act of 1933), which information is incorporated herein by
reference.
Item 2. Exhibits.
(1) Specimen Certificate for Shares of Common Stock of the
Registrant (incorporated by reference to Exhibit 4.1 to the
Registration Statement).
(2) Form of Restated Certificate of Incorporation of the
Registrant (incorporated by reference to Exhibit 3.3 to the
Registration Statement).
(3) Form of Amended and Restated By-laws of the Registrant
(incorporated by reference to Exhibit 3.5 to the
Registration Statement).
2
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the Registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereto duly authorized.
ALBANY MOLECULAR RESEARCH, INC.
By: /s/ Thomas E. D'Ambra, Ph.D.
------------------------------------------
Thomas E. D'Ambra, Ph.D.
Chairman of the Board and
Chief Executive Officer
Dated: January 29, 1999
3
